NasdaqCM - Nasdaq Real Time Price USD

Tempest Therapeutics, Inc. (TPST)

6.49
-0.36
(-5.26%)
At close: May 9 at 4:00:00 PM EDT
7.00
+0.51
+(7.86%)
After hours: May 9 at 7:38:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
42,026
42,026
29,157
34,640
26,986
Operating Income
-42,026
-42,026
-29,157
-34,640
-26,986
Net Non Operating Interest Income Expense
183
183
-334
-1,018
-1,275
Other Income Expense
--
--
15
-51
-41
Pretax Income
-41,843
-41,843
-29,491
-35,709
-28,302
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-41,843
-41,843
-29,491
-35,709
-28,302
Diluted NI Available to Com Stockholders
-41,843
-41,843
-29,491
-35,709
-28,302
Basic EPS
-1.53
-1.50
-1.91
-3.09
-7.47
Diluted EPS
-1.53
-1.50
-1.91
-3.09
-7.47
Basic Average Shares
22,525.04
27,901.74
15,416.20
11,556.31
3,790.30
Diluted Average Shares
22,525.04
27,901.74
15,416.20
11,556.31
3,790.30
Total Operating Income as Reported
-42,026
-42,026
-29,157
-34,640
-26,986
Total Expenses
42,026
42,026
29,157
34,640
26,986
Net Income from Continuing & Discontinued Operation
-41,843
-41,843
-29,491
-35,709
-28,302
Normalized Income
-41,843
-41,843
-29,491
-35,709
-28,302
Interest Income
1,499
1,499
1,115
600
7
Interest Expense
1,316
1,316
1,449
1,618
1,282
Net Interest Income
183
183
-334
-1,018
-1,275
EBIT
-40,527
-40,527
-28,042
-34,091
-27,020
EBITDA
-40,138
-40,138
-27,661
-33,453
-26,646
Reconciled Depreciation
389
389
381
638
374
Net Income from Continuing Operation Net Minority Interest
-41,843
-41,843
-29,491
-35,709
-28,302
Normalized EBITDA
-40,138
-40,138
-27,661
-33,453
-26,646
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/12/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PALI Palisade Bio, Inc.
0.7546
-1.35%
 
DRUG Bright Minds Biosciences Inc.
32.49
+1.34%
 
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
 
GNPX Genprex, Inc.
0.2853
-0.56%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
 
ALXO ALX Oncology Holdings Inc.
0.4223
-8.24%
 
APVO Aptevo Therapeutics Inc.
0.3400
-5.56%
 
CCCC C4 Therapeutics, Inc.
1.4700
-4.55%
 
CNTB Connect Biopharma Holdings Limited
0.8098
+1.23%
 
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%